|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0031325,
umls-concept:C0087111,
umls-concept:C0205419,
umls-concept:C0237401,
umls-concept:C0242640,
umls-concept:C0596902,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2603343,
umls-concept:C2911692
|
|
pubmed:issue |
9300
|
|
pubmed:dateCreated |
2002-1-25
|
|
pubmed:abstractText |
HIV-1-infected patients vary considerably by their response to antiretroviral treatment, drug concentrations in plasma, toxic events, and rate of immune recovery. This variability could have a genetic basis. We did a pharmacogenetics study to analyse the association between response to antiretroviral treatment and allelic variants of several genes.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
pubmed-author:BackDavid JDJ,
pubmed-author:BuclinThierryT,
pubmed-author:ChaveJean PhilippeJP,
pubmed-author:DecosterdLaurent ALA,
pubmed-author:EapChin BCB,
pubmed-author:FellayJacquesJ,
pubmed-author:FurrerHansjakobH,
pubmed-author:MarzoliniCatiaC,
pubmed-author:MeadenEmma RER,
pubmed-author:OpravilMilosM,
pubmed-author:PantaleoGiuseppeG,
pubmed-author:RetelskaDorotaD,
pubmed-author:RuizLidiaL,
pubmed-author:SchinkelAlfred HAH,
pubmed-author:Swiss HIV Cohort Study,
pubmed-author:TelentiAmalioA,
pubmed-author:VernazzaPietroP
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
5
|
|
pubmed:volume |
359
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
30-6
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11809184-Alleles,
pubmed-meshheading:11809184-Anti-HIV Agents,
pubmed-meshheading:11809184-Benzoxazines,
pubmed-meshheading:11809184-Chromatography, High Pressure Liquid,
pubmed-meshheading:11809184-Cytochrome P-450 Enzyme System,
pubmed-meshheading:11809184-Female,
pubmed-meshheading:11809184-Genes, MDR,
pubmed-meshheading:11809184-Genotype,
pubmed-meshheading:11809184-HIV Infections,
pubmed-meshheading:11809184-HIV Protease Inhibitors,
pubmed-meshheading:11809184-HIV-1,
pubmed-meshheading:11809184-Humans,
pubmed-meshheading:11809184-Logistic Models,
pubmed-meshheading:11809184-Male,
pubmed-meshheading:11809184-Nelfinavir,
pubmed-meshheading:11809184-Oxazines,
pubmed-meshheading:11809184-P-Glycoprotein,
pubmed-meshheading:11809184-Pharmacogenetics,
pubmed-meshheading:11809184-Polymerase Chain Reaction,
pubmed-meshheading:11809184-Prospective Studies,
pubmed-meshheading:11809184-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.
|
|
pubmed:affiliation |
Division of Infectious Diseases, University Hospital of Lausanne, Lausanne, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
